EX-32.1 13 d275067dex321.htm SARBANES-OXLEY ACT SECTION 906 CERTIFICATION OF MARK J. AHN AND CAITLIN KONTULIS

EXHIBIT 32.1

CERTIFICATION PURSUANT TO SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES

CODE, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, each of the undersigned, as principal executive officer and principal financial officer of Galena Biopharma, Inc. (the “Company”), does hereby certify that to such officer’s knowledge:

(1) the Company’s Form 10-K for the period ended December 31, 2011 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Company’s Form 10-K for the period ended December 31, 2011 fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Mark J. Ahn
Mark J. Ahn, Ph.D. President and Chief Executive Officer (Principal Executive Officer)
/s/ Kwang S. Lee
Kwang S. Lee
Vice President, Finance and Principal Accounting Officer (Principal Financial Officer)

Date: March 28, 2012